Colgate-Palmolive director John T. Cahill sells $389k in stock

On August 6, 2026, Colgate-Palmolive Co. director John T. Cahill sold 4,170 shares of the company's common stock, generating a total of $389,357. The shares were exchanged at a weighted average price of $93.3712 per share, ranging between $93.3712 and $93.39. This sale covered the exercise price of previously awarded stock options, allowing Cahill to buy back shares at $71.56 each, amounting to $298,405.

Following the transaction, Cahill now owns 28,373 shares directly and 36,357 indirectly via a trust. Colgate-Palmolive boasts a 56-year streak of dividend payments, currently yielding 4.61%. Investors can delve deeper into the company's valuation and financial standing through the InvestingPro Research Report, one of over 1,400 available for US equities.

Recently, Colgate-Palmolive reported Q2 earnings, beating expectations with a profit of $0.99 per share, matching revenue forecasts at $5.36 billion. Strong performance was driven by consistent organic growth and enhanced margins. Analyst reactions were favorable, with price targets raised by RBC Capital to $104 and TD Cowen to $90, both citing robust profitability.

Jefferies maintained a slight increase to $89, emphasizing the potential in emerging markets. Bernstein kept a Market Perform rating, recognizing Colgate-Palmolive's global leadership in Oral Care, particularly in Latin America.